PredictImmune

About:

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

Website: https://www.predictimmune.com/

Twitter/X: predictimmune/

Top Investors: Cambridge Innovation Capital, Business Growth Fund, Wellcome Trust, Innovate UK, Parkwalk Advisors

Description:

PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.